Back
Avalo Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
13
AVTX
Avalo Therapeutics
Last Price:
$3.87
Seasonality Move:
-1.86%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVTX is experiencing selling pressure, which indicates risk of future bearish movement.
Avalo Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.99 | Sell |
20-day SMA: | 4.52 | Sell |
50-day SMA: | 5.93 | Sell |
200-day SMA: | 8.52 | Sell |
8-day EMA: | 4.03 | Sell |
20-day EMA: | 4.52 | Sell |
50-day EMA: | 5.54 | Sell |
200-day EMA: | 17.39 | Sell |
Avalo Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.55 | Sell |
Relative Strength Index (14 RSI): | 32.72 | Sell |
Chaikin Money Flow: | -64347 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.1 - 5.06) | Sell |
Bollinger Bands (100): | (5.28 - 8.24) | Sell |
Avalo Therapeutics Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Avalo Therapeutics Stock
Is Avalo Therapeutics Stock a Buy?
-
Avalo Therapeutics share price is 3.91 while AVTX 8-day simple moving average is 3.99, which is a Sell signal.
-
The stock price of AVTX is 3.91 while Avalo Therapeutics 20-day SMA is 4.52, which makes it a Sell.
-
Avalo Therapeutics 50-day simple moving average is 5.93 while AVTX share price is 3.91, making it a Sell technically.
-
AVTX stock price is 3.91 and Avalo Therapeutics 200-day simple moving average is 8.52, creating a Sell signal.
AVTX Technical Analysis vs Fundamental Analysis
Sell
13
Avalo Therapeutics (AVTX)
is a Sell
Is Avalo Therapeutics a Buy or a Sell?
-
Avalo Therapeutics stock is rated a SellThe current Avalo Therapeutics [AVTX] share price is $3.91. The Score for AVTX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
Avalo Therapeutics Stock Info
Market Cap:
42.3M
Price in USD:
3.91
Share Volume:
89.6K
Avalo Therapeutics 52-Week Range
52-Week High:
16.00
52-Week Low:
3.39
Sell
13
Avalo Therapeutics (AVTX)
is a Sell
Avalo Therapeutics Share Price Forecast
-
What is the Avalo Therapeutics stock price today?The Avalo Therapeutics stock price is 3.91 USD today.
-
Will AVTX stock go up or go down?Avalo Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Avalo Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avalo Therapeutics is overvalued.
Is Avalo Therapeutics Stock a Buy?
-
Avalo Therapeutics share price is 3.91 while AVTX 8-day exponential moving average is 4.03, which is a Sell signal.
-
The stock price of AVTX is 3.91 while Avalo Therapeutics 20-day EMA is 4.52, which makes it a Sell.
-
Avalo Therapeutics 50-day exponential moving average is 5.54 while AVTX share price is 3.91, making it a Sell technically.
-
AVTX stock price is 3.91 and Avalo Therapeutics 200-day simple moving average is 17.39, creating a Sell signal.
Fundamental Analysis of Avalo Therapeutics
Is Avalo Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $2.91 per share, a decrease next quarter of $0.88 per share, a decrease this year of $17.29 per share, and an increase next year of $0.21 per share.
Technical Analysis of Avalo Therapeutics
Should I short Avalo Therapeutics stock?
-
AVTX Moving Average Covergence Divergence (MACD) indicator is -0.55, suggesting Avalo Therapeutics is a Sell
-
Avalo Therapeutics Relative Strength Index (RSI) is 32.72, which suggest Avalo Therapeutics is oversold
-
The Bollinger Bands (25) for Avalo Therapeutics is (4.1 - 5.06), which suggest Avalo Therapeutics is a Sell
-
The Bollinger Bands (100) for Avalo Therapeutics is (5.28 - 8.24), which suggest Avalo Therapeutics is a Sell
* Avalo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.